Robert C. G. Bracchi
Robert C. G. Bracchi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Fiona J. Woods
Committee on Safety of Medicines (Wales)
1 shared publicationJane Houghton
Committee on Safety of Medicines (Wales)
1 shared publicationPhilip A. Routledge
Departments of Pharmacology, Therapeutics and Toxicology and
1 shared publicationSimon A. Smail
Postgraduate Medicine, Wales College of Medicine, Clinical Pharmacology and Pharmacogenetics
1 shared publicationSimon Thomas
Wolfson Unit of Clinical Pharmacology, School of Clinical and Laboratory Sciences, University of Newcastle upon Tyne and
1 shared publication
Latest Publications
- 6 May 2005
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (2) , 221-223
A distance‐learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme
Aims: The effect of a distance‐learning package linked to educational credits on the rate and quality of spontaneous adverse drug reaction (ADR) reporting by general practitioners (GPs) and pharmacists in Wales was investigated.Methods: In April 2000, 477 GPs and 261 pharmacists enrolled in the 12 month programme.Results: The number and quality of yellow card reports improved compared with those of a control region in England (Northern Region).Conclusions: We conclude that an educational initiative in drug safety linked to incentives may be associated with a significant but perhaps short‐lived improvement in the rate and quality of ADR reporting.
- 6 May 2005
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (2) , 221-223
A distance‐learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme
Aims: The effect of a distance‐learning package linked to educational credits on the rate and quality of spontaneous adverse drug reaction (ADR) reporting by general practitioners (GPs) and pharmacists in Wales was investigated.Methods: In April 2000, 477 GPs and 261 pharmacists enrolled in the 12 month programme.Results: The number and quality of yellow card reports improved compared with those of a control region in England (Northern Region).Conclusions: We conclude that an educational initiative in drug safety linked to incentives may be associated with a significant but perhaps short‐lived improvement in the rate and quality of ADR reporting.